Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
Cryer BL, Sostek MB, Fort JG, Svensson O, Hwang C, Hochberg MC. Cryer BL, et al. Ann Med. 2011 Dec;43(8):594-605. doi: 10.3109/07853890.2011.625971. Epub 2011 Oct 22. Ann Med. 2011. PMID: 22017620 Free article. Clinical Trial.
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers.
Miner P Jr, Plachetka J, Orlemans E, Fort JG, Sostek M. Miner P Jr, et al. Among authors: sostek m. Aliment Pharmacol Ther. 2010 Aug;32(3):414-24. doi: 10.1111/j.1365-2036.2010.04361.x. Epub 2010 May 18. Aliment Pharmacol Ther. 2010. PMID: 20491746 Clinical Trial.
Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
Angiolillo DJ, Hwang C, Datto C, Desai B, Sostek M. Angiolillo DJ, et al. Among authors: sostek m. Clin Ther. 2011 Dec;33(12):1883-93. doi: 10.1016/j.clinthera.2011.10.009. Epub 2011 Nov 10. Clin Ther. 2011. PMID: 22078153 Clinical Trial.
Treatment of chronic posterior laryngitis with esomeprazole.
Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, Hwang C, Sostek MB, Shaker R. Vaezi MF, et al. Laryngoscope. 2006 Feb;116(2):254-60. doi: 10.1097/01.mlg.0000192173.00498.ba. Laryngoscope. 2006. PMID: 16467715 Clinical Trial.
Healing rates for moderate and severe oesophagitis.
Sostek MB, Hwang C. Sostek MB, et al. Aliment Pharmacol Ther. 2006 May 1;23(9):1373-4; author reply 1374-5. doi: 10.1111/j.1365-2036.2006.02832.x. Aliment Pharmacol Ther. 2006. PMID: 16629944 No abstract available.
55 results